The Ontario Personalized Medicine Network (OPMN) is led by an expert panel to assess the challenges and opportunities presented by personalized medicine. The objective of the OPMN is to ensure Ontario is well positioned to capitalize on the exciting and transformative technology revolutionizing the medical care landscape. Membership in the OPMN is voluntary. Contact Kathryn Deuchars for more information or to sign up.
The purpose of the OPMN is to help identify critical paths to enabling Personalized Medicine in Ontario. With the support of both the Ontario Ministry of Health and Long Term Care and the Ministry of Research, Innovation and Science, the OPMN is mandated to align existing resources and efforts to maximize the impact of personalized medicine in Ontario.
What is Personalized Medicine?
Personalized medicine is an approach to health care in which decisions are tailored to the individual using genetic information, and treatment is informed by a deep understanding of the genomic and molecular changes that contribute to the disease. The concept of personalized medicine is embodied by the expression “the right medicine to the right person, at the right dose and at the right time.”
Personalized medicine presents an incredible opportunity to revolutionize health care in Ontario and around the world. Genomics and related fields have improved our understanding of the human body and the relationships between genes, proteins and disease. Personalized medicine builds upon this knowledge and capability to provide more effective health care through improved:
- Prevention– assessing disease risk and taking action to prevent or delay onset and symptoms
- Diagnosis – identifying illness accurately and detecting at an earlier stage
- Treatment– targeting therapies to genetic traits, reducing side-effects and decreasing delays in finding the correct treatment and dose
- Patient engagement– allowing patients to monitor health and take action and improving compliance